Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Jul 21:S1542-3565(20)30996-4. doi: 10.1016/j.cgh.2020.07.034

Table 2:

Predictors of detection of high grade dysplasia or esophageal adenocarcinoma on initial surveillance endoscopy

Univariate OR (95% CI) P-Value Multivariate OR (95%
CI)
P-Value
Gender
Female REF REF
Male 4 (1.6-10.1) 0.0011 4.8 (1.58-14.74) 0.0056
Age
1-Year Increments 1.05 (1.03-1.08) <.0001 1.05 (1.02-1.09) 0.0001
Smoking
None REF REF
Current 2.6 (1-6.4) 0.0369 2.68 (0.89-8.02) 0.0780
Past 2.26 (1.1-4.6) 0.0247 1.97 (0.72-5.34) 0.1843
Provider
Non-Gastroenterologists REF REF
Gastroenterologists 3.6 (1.3-10) 0.0154 2.49 (0.84-7.31) 0.0971
Barrett’s Length
1 CM Increments 1.18 (1.09-1.26) <.0001 1.12 (1.02-1.21) 0.0116
Time Period
1991-2000 REF REF
2001-2010 8.16 (1.09-60.8) 0.0405 8.57 (0.91-66.80) 0.0601
2011-2019 9.48 (1.28-70.3) 0.0277 7.89 (0.75-62.676) 0.0926
Visible Abnormality on Endoscopy
Absent REF REF
Present 15.61 (8.11-30.05) <.0001 8.45 (3.69-19.34) <.0001
Reflux
Absent REF
Present 1.03 (0.59-1.8) 0.89
Dysphagia
Absent REF
Present 1.14 (0.54-2.3) 0.72
Iron Deficiency Anemia
Absent REF
Present 3.3 (1.8-6.1) <.0001
Dyspepsia
  Absent REF
  Present 0.19 (0.04-0.81) 0.0247
Hiatal Hernia
  Absent REF
  Present 1.19 (0.66-2.1) 0.54
BE Length/Bottle ratio*
Inadequate Biopsy REF
Adequate Biopsy 0.54 (0.42-1.3) 0.1141
*

Patients who had targeted biopsy were excluded from the analysis.